|
|
- Info
B8: SFB-relevante Publikationen
- Kyttälä
S., Habermann I., Minami T., Ehninger G., Kiani
A.
(2009): Regulation of Down Syndrome Critical Region 1 (DSCR1)
Expression by Nuclear Factor of Activated T cells (NFAT) in
Megakaryocytes. British Journal of Haematology 144 (3):395-408.
- Kiani
A.,
Kuithan H., Kuithan F., Kyttälä S., Habermann I., Temme A.,
Bornhäuser M., Ehninger G. (2007): Expression analysis of nuclear
factor of activated T cells (NFAT) during myeloid differentiation of
CD34+
cells: regulation of Fas ligand gene expression in megakaryocytes.
Experimental Hematology 35 (5):757-770.
- Kiani
A., Habermann I., Haase M., Feldmann S., Boxberger S.,
Sanchez-Fernandez Maria A., Thiede C., Bornhäuser M., Ehninger G.
(2004): Expression and Regulation of NFAT (Nuclear Factors of
Activated T cells) in Human CD34+
Cells: Downregulation Upon Myeloid Differentiation. Journal of
Leukocyte Biology 76 (5):1057-1065.
- Kiani
A.,
Garcia-Cozar F.J., Habermann I., Laforsch S., Aebischer T., Ehninger
G., Rao A. (2001): Regulation of interferon-
gene expression by Nuclear Factor of Activated T cells. Blood 98
(5):1480-1488.
- Kiani
A.,
Rao A., Aramburu J. (2000): Manipulating immune responses with
immunosuppressive agents that target NFAT (review). Immunity 12
(4):359-372.
- Viola
J.P.B., Kiani
A.,
Bozza P.T., Rao A. (1998): Allergic response in NFAT1-deficient mice:
Role of IL-4 and IL-5. Blood
91 (7): 2223-2230.
- Kiani
A.,
Viola J.P.B., Lichtman A.H., Rao A. (1997): Down-regulation of IL-4
gene transcription and control of Th2 differentiation by a mechanism
involving NFAT1. Immunity 7 (6):849-860.
|
-
September
| Mo | Di | Mi | Do | Fr | Sa | So |
|---|
| | 1 | 2 | 3 | 4 | 5 |
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | | | |
Funding program:
|
